Literature DB >> 27959686

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies.

Johan van Griensven1, Tansy Edwards2, Sylvain Baize3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959686      PMCID： PMC5833944          DOI： 10.1056/NEJMc1609116

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

Authors:  Johan van Griensven; Tansy Edwards; Xavier de Lamballerie; Malcolm G Semple; Pierre Gallian; Sylvain Baize; Peter W Horby; Hervé Raoul; N'Faly Magassouba; Annick Antierens; Carolyn Lomas; Ousmane Faye; Amadou A Sall; Katrien Fransen; Jozefien Buyze; Raffaella Ravinetto; Pierre Tiberghien; Yves Claeys; Maaike De Crop; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Alexandre Delamou; Anja De Weggheleire; Nyankoye Haba
Journal:  N Engl J Med       Date:  2016-01-07       Impact factor: 91.245

2.  Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.

Authors:  Tansy Edwards; Malcolm G Semple; Anja De Weggheleire; Yves Claeys; Maaike De Crop; Joris Menten; Raffaella Ravinetto; Sarah Temmerman; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Johan van Griensven
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486
  2 in total
  19 in total

1.  Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.

Authors:  Jerry F Brown; John M Dye; Sam Tozay; Gertrude Jeh-Mulbah; David A Wohl; William A Fischer; Coleen K Cunningham; Kathleen Rowe; Peter Zacharias; James van Hasselt; David A Norwood; Nathan M Thielman; Samantha E Zak; David L Hoover
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

Review 2.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

Review 3.  Clinical Evaluation of Ebola Virus Disease Therapeutics.

Authors:  Guodong Liu; Gary Wong; Shuo Su; Yuhai Bi; Frank Plummer; George F Gao; Gary Kobinger; Xiangguo Qiu
Journal:  Trends Mol Med       Date:  2017-08-17       Impact factor: 11.951

Review 4.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

Review 5.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

Review 6.  Use of convalescent plasma for COVID-19 in India: A review & practical guidelines.

Authors:  Niranjan Shiwaji Khaire; Nishant Jindal; Lakshmi Narayana Yaddanapudi; Suchet Sachdev; Rekha Hans; Naresh Sachdeva; Mini P Singh; Anup Agarwal; Aparna Mukherjee; Gunjan Kumar; Ratti Ram Sharma; Vikas Suri; Goverdhan Dutt Puri; Pankaj Malhotra
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

7.  Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology.

Authors:  Susan Yonemura; Lindsay Hartson; Taru S Dutt; Marcela Henao-Tamayo; Raymond Goodrich; Susanne Marschner
Journal:  Vox Sang       Date:  2021-04-09       Impact factor: 2.996

8.  Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.

Authors:  Melba F Gomes; Vânia de la Fuente-Núñez; Abha Saxena; Annette C Kuesel
Journal:  Reprod Health       Date:  2017-12-14       Impact factor: 3.223

Review 9.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

Review 10.  Ebola virus disease: an update on post-exposure prophylaxis.

Authors:  William A Fischer; Pauline Vetter; Daniel G Bausch; Timothy Burgess; Richard T Davey; Robert Fowler; Frederick G Hayden; Peter B Jahrling; Andre C Kalil; Douglas L Mayers; Aneesh K Mehta; Timothy M Uyeki; Michael Jacobs
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.